ClinicalTrials.gg
CompletedNCT07782151Updated Aug 24, 2026

Comparison of Pain Between Buccal Fat Pad and Buccal Advancement Flap

An interventional study of Buccal fat pad flap and Buccal advancement flap in Oroantral Fistula, sponsored by Asma Noureen. Completed at 1 site in Pakistan. Open to participants aged 30 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Asma Noureen · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Jun 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
30 Years to 60 Years
Sex
All
01

Study summary

This randomized controlled trial compares postoperative pain following surgical closure using a buccal fat pad flap versus a buccal advancement flap. The study aims to determine whether there is a difference in postoperative pain between the two surgical techniques in patients undergoing treatment for oroantral fistula. Pain will be assessed after surgery using the study's predefined pain assessment method.

02

Conditions studied

  • Oroantral Fistula

Browse trials for

Keywords

  • Oroantral fistula
  • Buccal Fat pad
  • Buccal advancement flap
  • Oroantral fistula closure
  • Postoperative pain
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's enrollment of 60 is below the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

This is the only study on the registry with Asma Noureen as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with clinically diagnosed oroantral fistula (OAF).
  • Age 30 to 60 years.
  • Both male and female patients who are Pakistani nationals.
  • Patients willing to continue with the study.

Exclusion criteria

Exclusion Criteria:

  • Patients with diabetes mellitus.
  • Patients with oral cancer.
  • Patients who have received head and neck radiotherapy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Buccal fat pad

    Participants assigned to this arm will undergo surgical closure using a buccal fat pad flap. Postoperative pain will be assessed and compared with the buccal advancement flap group.

    Procedure: Buccal fat pad flap

  • Active comparator
    Buccal advancement flap

    Participants assigned to this arm will undergo surgical closure using a buccal advancement flap. Postoperative pain will be assessed and compared with the buccal fat pad group.

    Procedure: Buccal advancement flap

Interventions

  • ProcedureBuccal fat pad flap

    Surgical closure using a buccal fat pad flap. Postoperative pain will be assessed following the procedure.

  • ProcedureBuccal advancement flap

    Surgical closure using a buccal advancement flap. Postoperative pain will be assessed following the procedure.

06

What researchers measure

Primary outcomes

  1. Postoperative pain measured by Visual Analogue Scale (VAS)

    Postoperative pain will be assessed using the Visual Analogue Scale (VAS) at 24 hours and 7 days after surgery. The VAS ranges from 0 to 100 mm, where 0 mm represents no pain and 100 mm represents the worst pain imaginable. Higher scores indicate greater pain and therefore a worse outcome. Pain scores will be compared between patients treated with buccal fat pad flap and buccal advancement flap.

    Time frame: 24 hours and 7 days post-operation

07

Study locations

1 site
  • Sharif Medical City Hospital
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07782151
Lead sponsor
Asma Noureen
Responsible party
Asma Noureen (Post Graduate Resident Oral and Maxillofacial Surgery, Sharif Medical Research Center) — Sponsor-investigator
First posted
Aug 24, 2026
Start date
Jun 9, 2025
Primary completion
Oct 8, 2025
Completion
Oct 8, 2025
Last update
Aug 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion